USDA Develops Candidate African Swine Fever Vaccine

Jun 10, 2021

By Greg Cima

A federal research team reported progress toward creating a commercial vaccine against the devastating African swine fever virus.

An article published in May in the Journal of Virology indicates Department of Agriculture scientists at the Plum Island Animal Disease Center in New York created an attenuated vaccine candidate that can reproduce in a continuous cell line, overcoming a limitation that previous vaccine candidates required fresh macrophages from live swine. USDA Agricultural Research Service scientists had developed a previous vaccine candidate that offered effective protection, but the macrophage requirements prevented large-scale production.

Two of the article authors—USDA ARS research microbiologists Manuel Borca, PhD, and Douglas Gladue, PhD—said in a joint message that the ASF virus requires primary swine macrophages to replicate, and those macrophages do not divide. The researchers adapted an ASF virus to reproduce in a cell line that was developed at the ARS from primary porcine epithelial cells, and the attenuated vaccine candidate they produced with that modified virus protected swine as well as their previous vaccine candidate.

Click here to see more...

Video: Unveiling a Breakthrough Genetic Solution for Future-Proof, Sustainable Pork Production

Marcel Huijsmans, Global Marketing Director at Topigs Norsvin tells us about their new genetic solution R3silience that offers a solid alternative to how the industry can approach disease management.

R3silience delivers scientifically proven, naturally resilient pigs that thrive under disease pressure, enabling more predictable, sustainable production by reducing losses and sustaining growth under disease challenge.

R3silience pigs deliver higher survival, stronger overall performance, and healthier herds - reducing wean-to-finish mortality by up to 6 percentage points during multifactorial PRRS outbreak*.

R3silience pigs not only show higher survival, but also deliver superior growth, improving daily weight gain by up to 0.04lbs. per day under multifactorial PRRS outbreak.*

Pigs with enhanced resilience to both viral and bacterial diseases require fewer health interventions and up to 8% less antibiotic treatments from wean-to-finish*, supporting better animal welfare.

For more information visit https://topigsnorsvin.com/products/r3...